The Association between Serum 25-Hydroxy Vitamin D Level and Urine Cathelicidin in Children with a Urinary Tract Infection

被引:29
作者
Hacihamdioglu, Duygu Ovunc [1 ]
Altun, Demet [2 ]
Hacihamdioglu, Bulent [1 ]
Cekmez, Ferhat [1 ]
Aydemir, Gokhan [1 ]
Kul, Mustafa [1 ]
Muftuoglu, Tuba [3 ]
Suleymanoglu, Selami [1 ]
Karademir, Ferhan [1 ]
机构
[1] Haydarpasa Training & Res Hosp, Gulhane Mil Med Acad, Pediat Clin, Istanbul, Turkey
[2] Etimesgut Mil Hosp, Ankara, Turkey
[3] Haydarpasa Training & Res Hosp, Gulhane Mil Med Acad, Clin Biochem, Istanbul, Turkey
关键词
Urinary tract infection; Escherichia coli; children; vitamin D; cathelicidin; ANTIMICROBIAL PEPTIDES; IMMUNITY;
D O I
10.4274/jcrpe.2563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Cathelicidin is an important antimicrobial peptide in the urinary tract. Cathelicidin expression is strongly stimulated by 1,25-dihydroxy vitamin D in epithelial cells, macrophages/monocytes, and neutrophils. Vitamin D and cathelicidin status in children with urinary tract infection (UTI) caused by Escherichia coli is unknown. To establish the relationship between serum vitamin D and urine cathelicidin levels in children with a UTI caused by Escherichia coli. Methods: Serum 25-hydroxy vitamin D and urine cathelicidin levels were measured in 36 patients with UTI (mean age 6.8 +/- 3.6 years, range: 0.25-12.6 years) and 38 controls (mean age 6.3 +/- 2.8 years, range: 0.42-13 years). Results: There were no significant differences in urine cathelicidin levels between the study and control groups (p>0.05). Eight (22.2%) patients in the study group and 21 (58.3%) children in the control group were found to have sufficient vitamin D (>= 20 ng/mL). Patients with sufficient vitamin D had higher urine cathelicidin levels than the controls with sufficient vitamin D (respectively 262.5 +/- 41.1 vs. 168 +/- 31.6 ng/mL, p= 0.001). There were no significant differences between the patients and controls with insufficient vitamin D (p> 0.05). Conclusion: The children with vitamin D insufficiency may not be able to increase their urine cathelicidin level during UTI caused by Escherichia coli. There is a need of prospective studies in order to prove a beneficial effect of vitamin D supplementation for the restoration of cathelicidin stimulation and consequently for prevention of UTI recurrence.
引用
收藏
页码:325 / 329
页数:5
相关论文
共 23 条
[1]   Vitamin D Deficiency in Children and Adolescents [J].
Andiran, Nesibe ;
Celik, Nurullah ;
Akca, Halise ;
Dogan, Guzide .
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2012, 4 (01) :25-29
[2]  
[Anonymous], 2009, NUTR REV
[3]   Vitamin D and autoimmunity: New aetiological and therapeutic considerations [J].
Arnson, Yoav ;
Amital, Howard ;
Shoenfeld, Yehuda .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) :1137-1142
[4]   Vitamin D receptor gene polymorphism in children with urinary tract infection [J].
Aslan, Sule ;
Akil, Ipek ;
Aslan, Gulcin ;
Onay, Huseyin ;
Ozyurt, Beyhan Cengiz ;
Ozkinay, Ferda .
PEDIATRIC NEPHROLOGY, 2012, 27 (03) :417-421
[5]  
Behrman RE, 2016, NELSON TXB PEDIAT, P2556
[6]  
Bitsori M, 2012, EXPERT REV ANTI-INFE, V10, P1153, DOI [10.1586/ERI.12.99, 10.1586/eri.12.99]
[7]   Vitamin D: a new anti-infective agent? [J].
Borella, Elisabetta ;
Nesher, Gideon ;
Israeli, Eitan ;
Shoenfeld, Yehuda .
STEROIDS IN NEUROENDOCRINE IMMUNOLOGY AND THERAPY OF RHEUMATIC DISEASES I, 2014, 1317 :76-83
[8]   Long-term, low-dose prophylaxis against urinary tract infections in young children [J].
Brandstrom, Per ;
Hansson, Sverker .
PEDIATRIC NEPHROLOGY, 2015, 30 (03) :425-432
[9]   The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection [J].
Chromek, Milan ;
Slamova, Zuzana ;
Bergman, Peter ;
Kovacs, Laszlo ;
Podracka, L'udmila ;
Ehren, Ingrid ;
Hokfelt, Tomas ;
Gudmundsson, Gudmundur H. ;
Gallo, Richard L. ;
Agerberth, Birgitta ;
Brauner, Annelie .
NATURE MEDICINE, 2006, 12 (06) :636-641
[10]   Urinary tract infection: new perspectives on a common disease [J].
Craig, JC .
CURRENT OPINION IN INFECTIOUS DISEASES, 2001, 14 (03) :309-313